Matinas BioPharma (MTNB) announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as ...

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith ...

Corporate reorganizations are nothing new, but the targeted reorganization of HEOR groups comes at a time of significant change in the operational and competitive landscape for biopharma.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The round is the second-largest in 2025 among the nearly two dozen venture firms tracked by BioPharma Dive. Eikon has now secured about $1.1 billion in venture dollars since its inception in 2019.

Featured here, the Cash Flow Statement for Matinas BioPharma Holdings Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities ...

Benitec Biopharma Inc. (NASDAQ:BNTC), a clinical-stage biotechnology company with a market capitalization of $264 million, is making waves in the gene therapy space with its... ByInvesting.com • 17 ...

All seven members of Arbutus Biopharma's board have resigned and been replaced by five new members, including the company's new chief executive. The virology-focused biotech company said Tuesday ...

1 Day MTNB -1.95% DJIA 0.37% Russell 2K -0.38% Health Care/Life Sciences -0.32% ...

With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet ...